NRX Pharmaceuticals NRXP
NASDAQ NRXP
$2.40 -0.23 (-8.75%)
At close: Oct 22, 2026 · 4:00 PM EDT

NRX Pharmaceuticals (NRXP) Short term Debt (2024 - 2026)

Updated

NRX Pharmaceuticals (NRXP) recorded Short term Debt of $412,000 in Q2 2026, up 9.0% from $378,000 a year earlier.

Analysis

NRX Pharmaceuticals (NRXP) Short term Debt (2024 - 2026) Analysis & Trends

At the end of FY2024, NRX Pharmaceuticals reported Short term Debt of $320,000.

  • The Q2 2026 figure is the highest quarterly Short term Debt since Q3 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn
10 NRX Pharmaceuticals 89.79 Mn 41.38 Mn 426,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 412,000.00
Sep 30, 2025 152,000.00
Jun 30, 2025 378,000.00
Dec 31, 2024 320,000.00
Sep 30, 2024 634,000.00
Jun 30, 2024 943,000.00
API Access

NRX Pharmaceuticals Short term Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=short-term-debt&ticker=NRXP&period=max&api_key=YOUR_API_KEY